Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

547 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
Nissen SE, Lincoff AM, Brennan D, Ray KK, Mason D, Kastelein JJP, Thompson PD, Libby P, Cho L, Plutzky J, Bays HE, Moriarty PM, Menon V, Grobbee DE, Louie MJ, Chen CF, Li N, Bloedon L, Robinson P, Horner M, Sasiela WJ, McCluskey J, Davey D, Fajardo-Campos P, Petrovic P, Fedacko J, Zmuda W, Lukyanov Y, Nicholls SJ; CLEAR Outcomes Investigators. Nissen SE, et al. N Engl J Med. 2023 Apr 13;388(15):1353-1364. doi: 10.1056/NEJMoa2215024. Epub 2023 Mar 4. N Engl J Med. 2023. PMID: 36876740 Clinical Trial.
Prognostic value of myeloperoxidase in patients with chest pain.
Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, Goormastic M, Pepoy ML, McErlean ES, Topol EJ, Nissen SE, Hazen SL. Brennan ML, et al. Among authors: nissen se. N Engl J Med. 2003 Oct 23;349(17):1595-604. doi: 10.1056/NEJMoa035003. N Engl J Med. 2003. PMID: 14573731 Free article.
Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.
Nissen SE, Tuzcu EM, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J, Orazem J, Magorien RD, O'Shaughnessy C, Ganz P; Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Investigators. Nissen SE, et al. N Engl J Med. 2005 Jan 6;352(1):29-38. doi: 10.1056/NEJMoa042000. N Engl J Med. 2005. PMID: 15635110 Free article. Clinical Trial.
Strategies to promote HDL-C: an emerging therapeutic target.
Nicholls SJ, Nissen SE. Nicholls SJ, et al. Among authors: nissen se. Eur Heart J. 2005 May;26(9):853-5. doi: 10.1093/eurheartj/ehi218. Epub 2005 Mar 11. Eur Heart J. 2005. PMID: 15764616 No abstract available.
Surrogate markers for atherosclerotic disease.
Sankatsing RR, de Groot E, Jukema JW, de Feyter PJ, Pennell DJ, Schoenhagen P, Nissen SE, Stroes ES, Kastelein JJ. Sankatsing RR, et al. Among authors: nissen se. Curr Opin Lipidol. 2005 Aug;16(4):434-41. doi: 10.1097/01.mol.0000174400.68938.f6. Curr Opin Lipidol. 2005. PMID: 15990593 Review.
547 results